1. Home
  2. FPS vs CORT Comparison

FPS vs CORT Comparison

Compare FPS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forgent Power Solutions Inc. Class A Common Stock

FPS

Forgent Power Solutions Inc. Class A Common Stock

BUY

Current Price

$24.36

Market Cap

8.7B

Sector

Energy

ML Signal

BUY

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$86.78

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPS
CORT
Founded
2023
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7B
9.7B
IPO Year
2026
2001

Fundamental Metrics

Financial Performance
Metric
FPS
CORT
Price
$24.36
$86.78
Analyst Decision
Strong Buy
Buy
Analyst Count
12
5
Target Price
$54.67
★ $141.00
AVG Volume (30 Days)
★ 8.3M
649.2K
Earning Date
11-12-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.09
Revenue
★ $1,420,059,000.00
$761,407,000.00
Revenue This Year
$79.09
$50.53
Revenue Next Year
$33.96
$48.90
P/E Ratio
★ $526.99
$1,194.51
Revenue Growth
★ 88.54
12.79
52 Week Low
$23.16
$28.66
52 Week High
$66.00
$126.38

Technical Indicators

Market Signals
Indicator
FPS
CORT
Relative Strength Index (RSI) 27.80 24.86
Support Level N/A $77.38
Resistance Level $40.48 $122.93
Average True Range (ATR) 2.42 6.12
MACD -1.46 -2.51
Stochastic Oscillator 6.58 7.50

Price Performance

Historical Comparison
FPS
CORT

About FPS Forgent Power Solutions Inc. Class A Common Stock

Forgent Power Solutions Inc is a designer and manufacturer of electrical distribution equipment used in data centers, the power grid and energy-intensive industrial facilities. It manufacture and sell include automatic transfer switches (ATS), dry type transformers, electrical houses (eHouse), generator connection cabinets, liquid filled transformers, panelboards, power distribution units (PDU), power skids, remote power panels (RPP), switchboards, switchgear, and tap boxes. The company is organized and operates as one reportable segment, which carries out business activities related to the design, development, manufacturing, and marketing of products and services.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: